相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidemiology of Hepatocellular Carcinoma
Katherine A. McGlynn et al.
HEPATOLOGY (2021)
Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
Matthias Pinter et al.
GUT (2021)
Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis
Minhong Shen et al.
CANCER RESEARCH (2021)
Activating a collaborative innate-adaptive immune response to control metastasis
Lijuan Sun et al.
CANCER CELL (2021)
Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma
Kohei Shigeta et al.
HEPATOLOGY (2020)
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical Cancer
Jyoti S. Mayadev et al.
JAMA ONCOLOGY (2020)
Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma A Randomized Clinical Trial
Yong Xia et al.
JAMA ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
Vicky Makker et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice
Alfred E. Chappell et al.
NUCLEIC ACIDS RESEARCH (2020)
Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease
Jessica L. Centa et al.
NATURE MEDICINE (2020)
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment
Runzhe Chen et al.
CLINICAL CANCER RESEARCH (2020)
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution
Alexej Ballhausen et al.
NATURE COMMUNICATIONS (2020)
Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival
Maria M. Coronel et al.
SCIENCE ADVANCES (2020)
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s
Takaaki Oba et al.
NATURE COMMUNICATIONS (2020)
Metabolism of immune cells in cancer
Robert D. Leone et al.
NATURE REVIEWS CANCER (2020)
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma
S. John Liu et al.
GENOME BIOLOGY (2020)
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer
Wenting Liao et al.
CANCER CELL (2019)
The Immune Subtypes and Landscape of Squamous Cell Carcinoma
Bailiang Li et al.
CLINICAL CANCER RESEARCH (2019)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Association of Intake of Whole Grains and Dietary Fiber With Risk of Hepatocellular Carcinoma in US Adults
Wanshui Yang et al.
JAMA ONCOLOGY (2019)
N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
Veronica J. Alexander et al.
EUROPEAN HEART JOURNAL (2019)
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
Huiying Han et al.
CANCER CELL (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
E. Antonio Chiocca et al.
NEURO-ONCOLOGY (2019)
Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway
Regina Cheuk-Lam Lo et al.
CELL DEATH AND DIFFERENTIATION (2018)
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
Jinyang Li et al.
IMMUNITY (2018)
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott et al.
NATURE MEDICINE (2018)
Principles for targeting RNA with drug-like small molecules
Katherine Deigan Warner et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Hydrogen peroxide-triggered gene silencing in mammalian cells through boronated antisense oligonucleotides
Shohei Mori et al.
CHEMICAL SCIENCE (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy
Yu Guo et al.
NATURE COMMUNICATIONS (2018)
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman et al.
CELL (2018)
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Lionel B. Ivashkiv
NATURE REVIEWS IMMUNOLOGY (2018)
A Novel Role of Astrocyte Elevated Gene-1 (AEG-1) in Regulating Nonalcoholic Steatohepatitis (NASH)
Jyoti Srivastava et al.
HEPATOLOGY (2017)
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis
Pin Liu et al.
HEPATOLOGY (2017)
Emerging molecular therapeutic targets for cholangiocarcinoma
Sumera Rizvi et al.
JOURNAL OF HEPATOLOGY (2017)
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Lindsay A. Becker et al.
NATURE (2017)
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Luksza et al.
NATURE (2017)
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Daniel R. Scoles et al.
NATURE (2017)
Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases
Kathleen M. Schoch et al.
NEURON (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides
Shiyu Wang et al.
NUCLEIC ACIDS RESEARCH (2017)
Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function
Flurin Item et al.
NATURE COMMUNICATIONS (2017)
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
Spencer C. Wei et al.
CELL (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Combination cancer immunotherapies tailored to the tumour microenvironment
Mark J. Smyth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
R. Dixon Dorand et al.
SCIENCE (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
MTDH-SND1 Interaction Is Crucial for Expansion and Activity of Tumor-Initiating Cells in Diverse Oncogene- and Carcinogen-Induced Mammary Tumors
Liling Wan et al.
CANCER CELL (2014)
Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition
Kai Zhu et al.
CLINICAL CANCER RESEARCH (2011)
MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer
Guohong Hu et al.
CANCER CELL (2009)
Astrocyte Elevated Gene-1: Far More Than Just a Gene Regulated in Astrocytes
Devanand Sarkar et al.
CANCER RESEARCH (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
